MedPath

A study to evaluate effectiveness of timolol on skin ulceration in breast carcinoma patients as a newer treatment.

Not Applicable
Completed
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2019/07/020078
Lead Sponsor
Bankura Sammilani Medical College and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All breast carcinoma patients above 18 years were included in the study.

Exclusion Criteria

1.patient below 18yrs old.

2.patient on Neoadjuvant chemotherapy.

3.patient with uncontrolled Diabetes.

4.Infected ulcer.

5.Patient on immuno-supression therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Breast ulcer was healed or size was reduced after 8 weeks.Timepoint: Breast ulcer was healed or size was reduced after 8 weeks.
Secondary Outcome Measures
NameTimeMethod
eed to palliative mastectomy for ulcer only will be reducedTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath